SCHEMBL31676161

SCHEMBL31676161

O=C1Cc2ccc(C(F)(F)F)cc2CN2CCCN12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP2 O95551 2/20 0.40
▸ DPP4 P27487 1/20 0.37
▸ SRD5A1 P18405 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ NOTUM Q6P988 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ DPP7 Q9UHL4 2/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ PARP10 Q53GL7 1/20 0.35
▸ NAMPT P43490 1/20 0.34
▸ AADAT Q8N5Z0 1/20 0.34
▸ HTR2A P28223 2/20 0.33
▸ HTR2C P28335 2/20 0.33
▸ HTR2B P41595 2/20 0.33
▸ FAP Q12884 1/20 0.33
▸ ACACB O00763 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25409744 0.76 CYP1A2 (0.39) KMT2ANOTUM
SCHEMBL31676052 0.74 AADAT (0.44) TDP2DPP4SRD5A1KMT2ANOTUM
SCHEMBL6586662 0.68 TDP2 (0.54) TDP2SRD5A1NOTUMPARP1PARP10
SCHEMBL25406983 0.66 TIPARP (0.34) KMT2ANOTUMMEN1L3MBTL1DPP7
Water SCHEMBL27598694 0.66 TDP2 (0.50) TDP2ALDH1A1TSHRPARP1PARP10
Ammonia Solution, Strong SCHEMBL28002037 0.66 TDP2 (0.50) TDP2NOTUMALDH1A1TSHRPARP1
SCHEMBL9491661 0.65 TDP2 (0.50) TDP2SRD5A1NOTUMPARP1PARP10
SCHEMBL27974149 0.64 TDP2 (0.49) TDP2TSHRPARP1PARP10AADAT
SCHEMBL8998844 0.64 LMNA (0.54) TDP2SRD5A1KMT2ANOTUMMEN1
SCHEMBL2056192 0.63 DPP7 (0.47) TDP2DPP4SRD5A1NOTUMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263416-A1 SPPL2a INHIBITORS INCYTE CORPORATION 2025-08-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250263416-A1 SPPL2a INHIBITORS SPPL2A, SPPL2B, BACE1 TDP2 1161/4885DPP4 41/4885SRD5A1 3820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback